BiotechTube
Home/Merakris Therapeutics/T. Christopher Broderick
TC

T. Christopher Broderick

Director & Chief Executive Officer

Merakris Therapeutics

Therapeutic Areas

Wound HealingOphthalmology

Merakris Therapeutics Pipeline

DrugIndicationPhase
MTX-001Venous Leg Ulcers (Chronic Wound Healing)Phase 2
Opticyte MatrixOphthalmic Surgical ProceduresCommercial
Dermacyte MatrixAdvanced Wound CareCommercial

Leadership Team at Merakris Therapeutics

DR
Dr. Roger Ilagan
Chief Scientific Officer
WE
Walter E. Daniels
Director
View full Merakris Therapeutics profile